Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Pharmaceuticals
Amprologix, a British start-up firm developing antibiotics that are effective against drug-resistant infections, has launched from the University of Plymouth to commercialize a new antibiotic, epidermicin. The antibiotic was initially recovered from a skin bacterium, Staphylococcus epidermidis. Ingenza, an industrial bioprocess expert, is helping Amprologix scale up epidermicin production and is also taking a stake in the new firm.
This article has been sent to the following recipient: